New York Life Investment Management LLC Y M Abs Therapeutics, Inc. Transaction History

New York Life Investment Management LLC

  • $9.63 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 05, 2024
SELL
$4.88 - $7.42 $9,872 - $15,010
-2,023 Reduced 2.85%
68,932 $470,000
Q3 2023

Nov 07, 2023
SELL
$4.86 - $7.23 $54,952 - $81,749
-11,307 Reduced 13.75%
70,955 $386,000
Q2 2023

Aug 04, 2023
SELL
$5.68 - $10.34 $360,941 - $657,065
-63,546 Reduced 43.58%
82,262 $558,000
Q1 2023

May 08, 2023
BUY
$2.83 - $5.11 $412,636 - $745,078
145,808 New
145,808 $730,000

Others Institutions Holding YMAB

# of Institutions
106
Shares Held
24.5M
Call Options Held
40.3K
Put Options Held
400
View Full List

About Y-mAbs Therapeutics, Inc.

YMAB Quotes by TradingView
  • Ticker YMAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,719,500
  • Market Cap $356M
  • Description
  • Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...
More about YMAB
Track This Portfolio

Track New York Life Investment Management LLC Portfolio

Follow New York Life Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York Life Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on New York Life Investment Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email